Post-viral olfactory dysfunction is a common cause of both short- and long-term smell alteration. The coronavirus pandemic further highlights the importance of post-viral olfactory dysfunction. Currently, a comprehensive review of the neural mechanism underpinning post-viral olfactory dysfunction is lacking.
Objectives
To synthesize the existing primary literature related to olfactory dysfunction secondary to viral infection, detail the underlying pathophysiological mechanisms, highlight relevance for the current COVID-19 pandemic, and identify high impact areas of future research.
Methods
PubMed and Embase were searched to identify studies reporting primary scientific data on post-viral olfactory dysfunction. Results were supplemented by manual searches. Studies were categorized into animal and human studies for final analysis and summary.
Results
A total of 38 animal studies and 7 human studies met inclusion criteria and were analyzed. There was significant variability in study design, experimental model, and outcome measured. Viral effects on the olfactory system varies significantly based on viral substrain but generally include damage or alteration in components of the olfactory epithelium and/or the olfactory bulb.
Conclusions
The mechanism of post-viral olfactory dysfunction is highly complex, virus-dependent, and involves a combination of insults at multiple levels of the olfactory pathway. This will have important implications for future diagnostic and therapeutic developments for patients infected with COVID-19.
CarfiABernabeiRLandiF, for the Gemelli Against COVID-19 Post-Acute Care Study Group.Persistent symptoms in patients after acute COVID-19. JAMA. 2020;
324(6):603.
2.
Vaira LA, Salzano G, Deiana G, Riu GD.
Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020;
130(7):1787.
3.
LechienJRChiesa-EstombaCMDe SiatiDR, et al.
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;
277(8):2251–2261.
4.
MoeinSTHashemianSMRMansourafsharB, et al.
Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020;
10(8):944–950.
5.
HenkinRILevyLMFordyceA.Taste and smell function in chronic disease: a review of clinical and biochemical evaluations of taste and smell dysfunction in over 5000 patients at the taste and smell clinic in Washington, DC. Am J Otolaryngol. 2013;
34(5):477–489.
6.
SeidenAM.Postviral olfactory loss. Otolaryngol Clin North Am. 2004;
37(6):1159–1166.
7.
van RielDVerdijkRKuikenT.The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol. 2015;
235(2):277–287.
8.
UehaRMukherjeeSUehaS, et al.
Viral disruption of olfactory progenitors is exacerbated in allergic mice. Int Immunopharmacol. 2014;
22(1):242–247.
9.
BrycheBFretaudMSaint-Albin DeliotA, et al.
Respiratory syncytial virus tropism for olfactory sensory neurons in mice. J Neurochem. 2019;e14936.
10.
FarrellHELawlerCTanCS, et al.
Murine cytomegalovirus exploits olfaction to enter new hosts. mBio. 2016;
7(2):e00251–e00216.
11.
XiangJZhangSNauwynckH.Infections of neonatal and adult mice with murine CMV HaNa1 strain upon oronasal inoculation: new insights in the pathogenesis of natural primary CMV infections. Virus Res. 2016;
211:96–102.
12.
ZhangSXiangJVan DoorsselaereJ, et al.
Comparison of the pathogenesis of the highly passaged MCMV smith strain with that of the low passaged MCMV HaNa1 isolate in BALB/c mice upon oronasal inoculation. Vet Res. 2015;
46:94–99.
13.
ArmienAGHuSLittleMR, et al.
Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis. Brain Pathol. 2010;
20(4):738–750.
14.
JennischeEErikssonCELangeS, et al.
The anterior commissure is a pathway for contralateral spread of herpes simplex virus type 1 after olfactory tract infection. J Neurovirol. 2015;
21(2):129–147.
15.
BeersDRHenkelJSSchaeferDC, et al.
Neuropathology of herpes simplex virus encephalitis in a rat seizure model. J Neuropathol Exp Neurol. 1993;
52(3):241–252.
16.
TomlinsonAHEsiriMM.Herpes simplex encephalitis. Immunohistological demonstration of spread of virus via olfactory pathways in mice. J Neurol Sci. 1983;
60(3):473–484.
17.
AndersonJRFieldHJ.The distribution of herpes simplex type 1 antigen in mouse Central nervous system after different routes of inoculation. J Neurol Sci. 1983;
60(2):181–195.
18.
MoriIGoshimaFWatanabeD, et al.
Herpes simplex virus US3 protein kinase regulates virus-induced apoptosis in olfactory and vomeronasal chemosensory neurons in vivo. Microbes Infect. 2006;
8(7):1806–1812.
19.
ChavesAJBusquetsNValleR, et al.
Neuropathogenesis of a highly pathogenic avian influenza virus (H7N1) in experimentally infected chickens. Vet Res. 2011;
42:106–111.
20.
BodewesRKreijtzJHvan AmerongenG, et al.
Pathogenesis of influenza a/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. Am J Pathol. 2011;
179(1):30–36.
21.
van den BrandJMStittelaarKJvan AmerongenG, et al.
Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets. PLoS One. 2012;
7(8):e42343.
22.
YamadaMBinghamJPayneJ, et al.
Multiple routes of invasion of wild-type clade 1 highly pathogenic avian influenza H5N1 virus into the central nervous system (CNS) after intranasal exposure in ferrets. Acta Neuropathol. 2012;
124(4):505–516.
23.
SchrauwenEJHerfstSLeijtenLM, et al.
The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. J Virol. 2012;
86(7):3975–3984.
24.
JangHBoltzDSturm-RamirezK, et al.
Highly pathogenic H5N1 influenza virus can enter the Central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci USA. 2009;
106(33):14063–14068.
25.
PlourdeJRPylesJALaytonRC, et al.
Neurovirulence of H5N1 infection in ferrets is mediated by multifocal replication in distinct permissive neuronal cell regions. PLoS One. 2012;
7(10):e46605.
26.
ShinyaKMakinoAHattaM, et al.
Subclinical brain injury caused by H5N1 influenza virus infection. J Virol. 2011;
85(10):5202–5207.
27.
ParkCHIshinakaMTakadaA, et al.
The invasion routes of neurovirulent a/Hong Kong/483/97 (H5N1) influenza virus into the Central nervous system after respiratory infection in mice. Arch Virol. 2002;
147(7):1425–1436.
28.
IwasakiTItamuraSNishimuraH, et al.
Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation. Acta Neuropathol. 2004;
108(6):485–492.
29.
de WitESiegersJYCroninJM, et al.
1918 H1N1 influenza virus replicates and induces proinflammatory cytokine responses in extrarespiratory tissues of ferrets. J Infect Dis. 2018;
217(8):1237–1246.
30.
Leyva-GradoVHChurchillLWuM, et al.
Influenza virus- and cytokine-immunoreactive cells in the murine olfactory and central autonomic nervous systems before and after illness onset. J Neuroimmunol. 2009;
211(1–2):73–83.
31.
MajdeJABohnetSGEllisGA, et al.
Detection of mouse-adapted human influenza virus in the olfactory bulbs of mice within hours after intranasal infection. J Neurovirol. 2007;
13(5):399–409.
32.
MoriIGoshimaFImaiY, et al.
Olfactory receptor neurons prevent dissemination of neurovirulent influenza a virus into the brain by undergoing virus-induced apoptosis. J Gen Virol. 2002;
83(Pt 9):2109–2116.
33.
AronssonFRobertsonBLjunggrenHG, et al.
Invasion and persistence of the neuroadapted influenza virus a/WSN/33 in the mouse olfactory system. Viral Immunol. 2003;
16(3):415–423.
34.
WheelerDLSariolAMeyerholzDK, et al.
Microglia are required for protection against lethal coronavirus encephalitis in mice. J Clin Invest. 2018;
128(3):931–943.
35.
TsaiJCde GrootLPinonJD, et al.
Amino acid substitutions within the heptad repeat domain 1 of murine coronavirus spike protein restrict viral antigen spread in the central nervous system. Virology. 2003;
312(2):369–380.
36.
NetlandJMeyerholzDKMooreS, et al.
Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;
82(15):7264–7275.
37.
SchwartzTFuLLaviE.Differential induction of apoptosis in demyelinating and nondemyelinating infection by mouse hepatitis virus. J Neurovirol. 2002;
8(5):392–399.
38.
SchwobJESahaSYoungentobSL, et al.
Intranasal inoculation with the olfactory bulb line variant of mouse hepatitis virus causes extensive destruction of the olfactory bulb and accelerated turnover of neurons in the olfactory epithelium of mice. Chem Senses. 2001;
26(8):937–952.
39.
YoungentobSLSchwobJESahaS, et al.
Functional consequences following infection of the olfactory system by intranasal infusion of the olfactory bulb line variant (OBLV) of mouse hepatitis strain JHM. Chem Senses. 2001;
26(8):953–963.
40.
BihunCGPercyDH.Morphologic changes in the nasal cavity associated with sialodacryoadenitis virus infection in the wistar rat. Vet Pathol. 1995;
32(1):1–10.
41.
TianJPintoJMCuiX, et al.
Sendai virus induces persistent olfactory dysfunction in a murine model of PVOD via effects on apoptosis, cell proliferation, and response to odorants. PLoS One. 2016;
11(7):e0159033.
42.
MoriINakakukiKKimuraY.Temperature-sensitive parainfluenza type 1 vaccine virus directly accesses the Central nervous system by infecting olfactory neurons. J Gen Virol. 1996;
77(9):2121–2124.
43.
MyersLJNusbaumKESwangoLJ, et al.
Dysfunction of sense of smell caused by canine parainfluenza virus infection in dogs. Am J Vet Res. 1988;
49(2):188–190.
44.
LundhBKristenssonKNorrbyE.Selective infections of olfactory and respiratory epithelium by vesicular stomatitis and sendai viruses. Neuropathol Appl Neurobiol. 1987;
13(2):111–122.
45.
MoriIKomatsuTTakeuchiK, et al.
Parainfluenza virus type 1 infects olfactory neurons and establishes long-term persistence in the nerve tissue. J Gen Virol. 1995;
76(5):1251–1254.
46.
AltundagATemirbekovDHaciC, et al. Olfactory cleft width and volume: possible risk factors for postinfectious olfactory dysfunction [published online ahead of print February 6, 2020]. Laryngoscope. doi:10.1002/lary.28524
47.
WolfALiesingerLSpoerkS, et al.
Olfactory cleft proteome does not reflect olfactory performance in patients with idiopathic and postinfectious olfactory disorder: a pilot study. Sci Rep. 2018;
8(1):17554–17512.
48.
YaoLYiXPintoJM, et al.
Olfactory cortex and olfactory bulb volume alterations in patients with post-infectious olfactory loss. Brain Imag Behav. 2018;
12(5):1355–1362.
49.
KimYKHongSLYoonEJ, et al.
Central presentation of postviral olfactory loss evaluated by positron emission tomography scan: a pilot study. Am J Rhinol Allergy. 2012;
26(3):204–208.
50.
RombauxPMartinageSHuartC, et al.
Post-infectious olfactory loss: a cohort study and update. B-ENT. 2009;
5(Suppl 13):89–95.
51.
RombauxPMourauxABertrandB, et al.
Olfactory function and olfactory bulb volume in patients with postinfectious olfactory loss. Laryngoscope. 2006;
116(3):436–439.
52.
YamagishiMFujiwaraMNakamuraH.Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection. Rhinology. 1994;
32(3):113–118.
53.
YoungentobSLSchwobJESheehePR, et al.
Odorant threshold following methyl bromide-induced lesions of the olfactory epithelium. Physiol Behav. 1997;
62(6):1241–1252.
54.
WangJHKwonHJJangYJ.Detection of parainfluenza virus 3 in turbinate epithelial cells of postviral olfactory dysfunction patients. Laryngoscope. 2007;
117(8):1445–1449.
55.
BrannDTsukaharaTWeinrebC, et al.
Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients. bioRxiv. 2020:2020.2003.2025.009084.
56.
HoffmannMKleine-WeberHSchroederS, et al.
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;
181(2):271–207.
57.
LiWMooreMJVasilievaN, et al.
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;
426(6965):450–454.
58.
SlotnickBCockerhamRPickettE.Olfaction in olfactory bulbectomized rats. J Neurosci. 2004;
24(41):9195–9200.
59.
LuXCSlotnickBM.Olfaction in rats with extensive lesions of the olfactory bulbs: implications for odor coding. Neuroscience. 1998;
84(3):849–866.
60.
SlotnickBMGutmanLA.Evaluation of intranasal zinc sulfate treatment on olfactory discrimination in rats. J Comp Physiol Psychol. 1977;
91(4):942–950.
61.
McGrathNAndersonNECroxsonMC, et al.
Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry. 1997;
63(3):321–326.
62.
RombauxPMourauxABertrandB, et al.
Can we smell without an olfactory bulb?Am J Rhinol. 2007;
21(5): 548–550.
63.
WeissTSorokaTGorodiskyL, et al.
Human olfaction without apparent olfactory bulbs. Neuron. 2020;
105(1):35–45.
64.
KollndorferKJakabAMuellerCA, et al.
Effects of chronic peripheral olfactory loss on functional brain networks. Neuroscience. 2015;
310:589–599.
65.
HosseiniSWilkEMichaelsen-PreusseK, et al.
Long-Term neuroinflammation induced by influenza a virus infection and the impact on hippocampal neuron morphology and function. J Neurosci. 2018;
38(12):3060–3080.
66.
EspinozaJABohmwaldKCespedesPF, et al.
Impaired learning resulting from respiratory syncytial virus infection. Proc Natl Acad Sci USA. 2013;
110(22):9112–9117.
MartinSJGrimwoodPDMorrisRG.Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci. 2000;
23:649–711.
69.
DammMPikartLKReimannH, et al.
Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope. 2014;
124(4):826–831.
70.
HummelTRissomKRedenJ, et al.
Effects of olfactory training in patients with olfactory loss. Laryngoscope. 2009;
119(3):496–499.
71.
TemmelAFQuintCSchickinger-FischerB, et al.
Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg. 2002;
128(6):635–641.
72.
LynchGRexCSGallCM.Synaptic plasticity in early aging. Ageing Res Rev. 2006;
5(3):255–280.
73.
Garcia-SeguraLMChowenJAParduczA, et al.
Gonadal hormones as promoters of structural synaptic plasticity: cellular mechanisms. Prog Neurobiol. 1994;
44(3):279–307.
SultanBMayLALaneAP.The role of TNF-alpha in inflammatory olfactory loss. Laryngoscope. 2011;
121(11): 2481–2486.
76.
PozharskayaTLaneAP.Interferon gamma causes olfactory dysfunction without concomitant neuroepithelial damage. Int Forum Allergy Rhinol. 2013;
3(11):861–865.
